Articles from Biotech Business (December 1, 2003)

Title	Author	Type	Words
ADAPTIVE MUTATION IS COMMON IN E.COLI.			708
CERUS INITIATES PHASE IB CLINICAL TRIAL FOR ACIT.			622
GUAVA VIACOUNT FLEX ALLOWS NON-MAMMALIAN CELL COUNT/ASSESSMENT.			527
LEVAQUIN GETS FDA APPROVAL FOR 5-DAY TREATMENT OF CAP.			671
LOCUS LICENSES GP41 CRYSTAL STRUCTURE FROM CORNELL RESEARCH.			471